Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification
AssigneeNavix, Inc.
InventorsJozsef Hepp, Zsolt Lengyel, Rajiv Pande
Life of this patent
Estimating the term…
Loading patent…
AssigneeNavix, Inc.
InventorsJozsef Hepp, Zsolt Lengyel, Rajiv Pande
Estimating the term…
The present invention relates to a method, kit and reagent composition for determining the presence of a target nucleic acid in a sample using a two-stage target cycling reaction. During stage 1 of the reaction, the target nucleic acid hybridizes with a probe nucleic acid to effectuate release of an activator into the assay medium. During stage 2 of the reaction, a target analog-anchor complex is cleaved by the activator, which accomplishes the dual purpose of releasing the target analog into the assay medium, and the initiation of signal generation. The released target analog then restarts the cyclic reaction by binding to a second probe, which effectuates release of a second activator, and so on. This cyclic reaction gives rise to an increase in the amount of signal generated from a single target nucleic acid molecule in the sample, which greatly enhances the level of target detection that can be expected.
A method for performing a nucleic acid hybridization assay in an assay system, said method being useful for determining the presence of a target nucleic acid having a target nucleic acid sequence in a sample suspected of containing said target nucleic acid, comprising the steps of:
An assay system for determining the presence of a target nucleic acid having a target nucleic acid sequence in a sample suspected of containing said target nucleic acid comprising:
A reagent composition for increasing sensitivity of a nucleic acid hybridization assay between a probe nucleic acid, and a target nucleic acid having a target nucleic acid sequence comprising:
Dependencies are inferred from the claim text.